Dr Fiona Jenkinson
| Consistency in the Assessment of Dried Blood Spot Specimen Size and Quality in U.K. Newborn Screening Laboratories | 2024 |
|
Dr Fiona Jenkinson
| Ethnic Diversity and Distinctive Features of Familial Versus Multifactorial Chylomicronemia Syndrome: Insights from the UK FCS National Registry | 2024 |
|
Dr Fiona Jenkinson
| Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS) | 2024 |
|
Dr Fiona Jenkinson
| Long-term effects of volanesorsen on triglycerides and pancreatitis in patients with familial chylomicronaemia syndrome (FCS) in the UK Early Access to Medicines Scheme (EAMS) | 2023 |
|
Dr Christopher Bacon
Dr George Petrides
Dr Nicola Leech
Dr Fiona Jenkinson
Professor Ruth Plummer
et al. | A case of malignant hyperlactaemic acidosis appearing on treatment with the mono-carboxylase transporter 1 inhibitor AZD3965. | 2020 |
|
Dr Jakub Bukowczan
Dr Fiona Jenkinson
Dr Richard Quinton
| Regan isoenzyme of alkaline phosphatase as a tumour marker for renal cell carcinoma | 2014 |
|
